{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:55:13Z","timestamp":1791374113777,"version":"4.3.1"},"reference-count":26,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mirt"],"DOI":"10.4274\/mirt.galenos.2026.92653","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:31:24Z","timestamp":1791289884000},"source":"Crossref","is-referenced-by-count":0,"title":["Papillary Thyroid Microcarcinomas Detected by Nuclear Medicine Imaging: Distinct Clinicopathological Features Compared with Conventional Modalities"],"prefix":"10.4274","author":[{"given":"Seda Hanife","family":"O\u011fuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Ert\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcrsan","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenk","family":"S\u00f6kmens\u00fcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jale","family":"Karakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat Fani","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"G\u00fcrlek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/lary.27664","article-title":"Incidental thyroid papillary microcarcinoma: survival and follow-up","volume":"129","author":"Gorostis","year":"2019","unstructured":"1. Gorostis S, Raguin T, Schneegans O, Takeda C, Debry C, Dupret-Bories A. Incidental thyroid papillary microcarcinoma: survival and follow-up. Laryngoscope. 2019;129:1722-1726.","journal-title":"Laryngoscope"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3892\/ol.2016.4640","article-title":"Incidental and non-incidental thyroid microcarcinoma","volume":"12","author":"Kaliszewski","year":"2016","unstructured":"2. Kaliszewski K, Wojtczak B, Strutynska-Karpinska M, Lukienczuk T, Forkasiewicz Z, Do-moslawski P. Incidental and non-incidental thyroid microcarcinoma. Oncol Lett. 2016;12:734-740.","journal-title":"Oncol Lett"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.amjsurg.2013.02.008","article-title":"Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcino-ma","volume":"206","author":"Karatzas","year":"2013","unstructured":"3. Karatzas T, Vasileiadis I, Kapetanakis S, Karakostas E, Chrousos G, Kouraklis G. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcino-ma. Am J Surg. 2013;206:586-593.","journal-title":"Am J Surg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1210\/jc.2013-2118","article-title":"Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid mi-crocarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up","volume":"99","author":"Mehanna","year":"2014","unstructured":"4. Mehanna H, Al-Maqbili T, Carter B, Martin E, Campain N, Watkinson J, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid mi-crocarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab. 2014;99:2834-2843.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/hed.23333","article-title":"Clin-ical and pathological characteristics of incidental and nonincidental papillary thyroid micro-carcinoma in 339 patients","volume":"36","author":"Vasileiadis","year":"2014","unstructured":"5. Vasileiadis I, Karatzas T, Vasileiadis D, Kapetanakis S, Charitoudis G, Karakostas E, et al. Clin-ical and pathological characteristics of incidental and nonincidental papillary thyroid micro-carcinoma in 339 patients. Head Neck. 2014;36:564-570.","journal-title":"Head Neck"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1210\/jc.2012-2390","article-title":"Diagnostic and clinical significance of F-18-FDG-PET\/CT thyroid incidentalomas","volume":"97","author":"Bertagna","year":"2012","unstructured":"6. Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET\/CT thyroid incidentalomas. J Clin Endocrinol Metab. 2012;97:3866-5875.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"723394","DOI":"10.3389\/fendo.2021.723394","article-title":"Front endocrinol","volume":"12","author":"de Leijer","year":"2021","unstructured":"7. de Leijer JF, Metman MJH, van der Hoorn A, Brouwers AH, Kruijff S, van Hemel BM, Links TP, Westerlaan HE. Focal thyroid incidentalomas on (18)F-FDG PET\/CT: a systematic review and meta-analysis on prevalence, risk of malignancy and inconclusive fine needle aspiration. Front endocrinol. (Lausanne). 2021;12:723394.","journal-title":"(Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MNM.0000000000000495","article-title":"Clinical significance of thyroid in-cidentalomas identified by 18F-FDG PET\/CT: correlation of ultrasonography findings with cytol-ogy results","volume":"37","author":"Demir","year":"2016","unstructured":"8. Demir O, Kose N, Ozkan E, Unluturk U, Aras G, Erdogan MF. Clinical significance of thyroid in-cidentalomas identified by 18F-FDG PET\/CT: correlation of ultrasonography findings with cytol-ogy results. Nucl Med Commun. 2016;37:715-20.","journal-title":"Nucl Med Commun"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0194599814530861","article-title":"The proportion of malignancy in incidental thyroid lesions on 18-FDG PET study: a systematic review and meta-analysis","volume":"151","author":"Nayan","year":"2014","unstructured":"9. Nayan S, Ramakrishna J, Gupta MK. The proportion of malignancy in incidental thyroid lesions on 18-FDG PET study: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2014;151:190-200.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12020-019-01841-z","article-title":"F18-choline\/C11-choline PET\/CT thy-roid incidentalomas","volume":"64","author":"Bertagna","year":"2019","unstructured":"10. Bertagna F, Albano D, Giovanella L, Giubbini R, Treglia G. F18-choline\/C11-choline PET\/CT thy-roid incidentalomas. Endocrine. 2019;64:203-208.","journal-title":"Endocrine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/MNM.0000000000000692","article-title":"Value of 99mTc-MIBI SPECT\/CT parathyroid imaging and ultrasonography for concomitant thyroid carcinoma","volume":"38","author":"Guo","year":"2017","unstructured":"11. Guo R, Wang J, Zhang M, Zhang M, Meng H, Meng H, Zhang Y, Li B. Value of 99mTc-MIBI SPECT\/CT parathyroid imaging and ultrasonography for concomitant thyroid carcinoma. Nucl Med Commun. 2017;38:676-682.","journal-title":"Nucl Med Commun"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1245\/s10434-007-9531-4","article-title":"Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carci-nomas","volume":"14","author":"Are","year":"2007","unstructured":"12. Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carci-nomas. Ann Surg Oncol. 2007;14:3210-3215.","journal-title":"Ann Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Familiar C, Merino S, Valhondo R, Lopez C, Perez X, De Los Monteros PE, Hern\u00e1ndez F, Pazos M, Pallar\u00e9s R, Pascual AC. Prevalence and clinical significance in our setting of incidental up-take in the thyroid gland found on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT). Endocrinol Diabetes Nutr (Engl Ed). 2023;70:171-178.","DOI":"10.1016\/j.endien.2023.03.001"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1245\/s10434-010-1287-6","article-title":"Incidental thyroid carcinoma by FDG-PET\/CT: a study of clinicopathological characteristics","volume":"18","author":"TT","year":"2011","unstructured":"14. Law TT, Lang BH. Incidental thyroid carcinoma by FDG-PET\/CT: a study of clinicopathological characteristics. Ann Surg Oncol. 2011;18:472-478.","journal-title":"Ann Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.annpat.2017.10.003","article-title":"[Classification of pancreatic neuroendocrine tumours: changes made in the 2017 WHO classification of tumours of endocrine organs and perspec-tives for the future]","volume":"37","author":"Scoazec","year":"2017","unstructured":"15. Scoazec JY, Couvelard A, Reseau T. [Classification of pancreatic neuroendocrine tumours: changes made in the 2017 WHO classification of tumours of endocrine organs and perspec-tives for the future]. Ann Pathol. 2017;37:444-456.","journal-title":"Ann Pathol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2265.2011.04107.x","article-title":"Thyroid incidentaloma identified by (1)(8)F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET\/CT): clinical and patho-logical relevance","volume":"75","author":"Pagano","year":"2011","unstructured":"16. Pagano L, Sama MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M, Isidoro C, Aimaretti G. Thyroid incidentaloma identified by (1)(8)F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET\/CT): clinical and patho-logical relevance. Clin Endocrinol (Oxf). 2011;75:528-534.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.ejso.2014.05.005","article-title":"Thyroid incidentalomas discovered on positron emis-sion tomography CT scanning - malignancy rate and significance of standardised uptake val-ues","volume":"40","author":"Brindle","year":"2014","unstructured":"17. Brindle R, Mullan D, Yap BK, Gandhi A. Thyroid incidentalomas discovered on positron emis-sion tomography CT scanning - malignancy rate and significance of standardised uptake val-ues. Eur J Surg Oncol. 2014;40:1528-1532.","journal-title":"Eur J Surg Oncol"},{"key":"ref17","unstructured":"18. Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET\/CT: clinical significance and improved characterization. J Nucl Med. 2006;47:609-615."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3803\/EnM.2015.30.1.71","article-title":"Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography","volume":"30","author":"Chun","year":"2015","unstructured":"19. Chun AR, Jo HM, Lee SH, Chun HW, Park JM, Kim KJ, Jung CH, Mok JO, Kang SK, Kim CH, Kim BY. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Endocrinol Metab (Seoul). 2015;30:71-77.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4274\/mirt.94695","article-title":"Thyroid incidentalomas on (18)F-FDG PET\/CT: clinical significance and controversies","volume":"26","author":"Makis","year":"2017","unstructured":"20. Makis W, Ciarallo A. Thyroid incidentalomas on (18)F-FDG PET\/CT: clinical significance and controversies. Mol Imaging Radionucl Ther. 2017;26:93-100.","journal-title":"Mol Imaging Radionucl Ther"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Toyoshima MTK, Zuppani RMF, Amaro IP, de Macedo C, de Freitas RMC, Velasques RD, Pereira J, Batista RL, Danilovic DLS, Louren\u00e7o DM Jr, Hoff AO. Endocrine implications of thyroid inci-dentalomas detected during lymphoma staging with 18F-fluorodeoxyglucose positron emis-sion tomography. Clin Endocrinol (Oxf). 2025.","DOI":"10.1111\/cen.15295"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s00259-014-2774-y","article-title":"(1)(8)F-FDG uptake as a prog-nostic variable in primary differentiated thyroid cancer incidentally detected by PET\/CT: a multi-centre study","volume":"41","author":"Piccardo","year":"2014","unstructured":"22. Piccardo A, Puntoni M, Bertagna F, Treglia G, Foppiani L, Arecco F, Giubbini R, Naseri M, Cista-ro A, Cabria M, Bardesono F, Ceriani L, Orlandi F, Giovanella L. (1)(8)F-FDG uptake as a prog-nostic variable in primary differentiated thyroid cancer incidentally detected by PET\/CT: a multi-centre study. Eur J Nucl Med Mol Imaging. 2014;41:1482-1491.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Pak K, Cheon GJ, Lee KE, Park YJ, Choi HS, Min HS, Kang KW, Chung JK, Kim EE, Lee DS. Inci-dental thyroid cancer detected by (18)F-FDG PET: does it have different clinicopathological fea-tures? Nucl Med Commun. 2014;35:453-458.","DOI":"10.1097\/MNM.0000000000000076"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1089\/thy.2024.0142","article-title":"The association between lymphocytic thyroiditis and papillary thyroid cancer harboring mutant BRAF: a systematic re-view and meta-analysis","volume":"34","author":"Perampalam","year":"2024","unstructured":"24. Perampalam S, Wu K, Gild M, Tacon L, Bullock M, Clifton-Bligh R. The association between lymphocytic thyroiditis and papillary thyroid cancer harboring mutant BRAF: a systematic re-view and meta-analysis. Thyroid. 2024;34:1082-1093.","journal-title":"Thyroid"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13000-024-01495-0","article-title":"Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report","volume":"19","author":"Xu","year":"2024","unstructured":"25. Xu T, Wu L, Ye H, Luo S, Wang J. Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report. Diagn Pathol. 2024;19:69.","journal-title":"Diagn Pathol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12022-010-9124-9","article-title":"Features of papillary thyroid microcarcinoma in the presence and ab-sence of lymphocytic thyroiditis","volume":"21","author":"Kim","year":"2010","unstructured":"26. Kim HS, Choi YJ, Yun JS. Features of papillary thyroid microcarcinoma in the presence and ab-sence of lymphocytic thyroiditis. Endocr Pathol. 2010;21:149-153.","journal-title":"Endocr Pathol"}],"container-title":["Molecular Imaging and Radionuclide Therapy"],"original-title":[],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:26:18Z","timestamp":1791372378000},"score":1,"resource":{"primary":{"URL":"https:\/\/mirt.tsnmjournals.org\/articles\/papillary-thyroid-microcarcinomas-detected-by-nuclear-medicine-imaging-distinct-clinicopathological-features-compared-with-conventional-modalities\/doi\/mirt.galenos.2026.92653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":26,"URL":"https:\/\/doi.org\/10.4274\/mirt.galenos.2026.92653","relation":{},"ISSN":["2146-1414","2147-1959"],"issn-type":[{"value":"2146-1414","type":"print"},{"value":"2147-1959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}